Essential thrombocythemia with portal vein thrombosis and splenic infarction successfully treated with platelet apheresis.
Ami Mehul MehtaShubha SeshadriSeemitr VermaSharath P MadhyasthaPublished in: BMJ case reports (2021)
A 63-year-old diabetic woman presented to the outpatient clinic with a 1-week history of abdominal pain. On complete evaluation, she was diagnosed to have essential thrombocythemia. Abdominal imaging revealed portal vein thrombosis with a large splenic infarct. The patient was started on anticoagulant, antiplatelet and cytoreductive therapy. In view of persistent high platelet count, plasma apheresis was done, following which the patient's platelet counts were reduced. Essential thrombocythemia has a high rate of complications, resulting in significant morbidity and mortality. Few cases of this disease and its treatment have been described in the literature, especially pertaining to the Indian scenario. Further studies are needed to establish a multidisciplinary algorithm for its diagnosis and to elucidate the guidelines for the successful treatment of the condition.
Keyphrases
- case report
- abdominal pain
- pulmonary embolism
- systematic review
- high resolution
- atrial fibrillation
- primary care
- peripheral blood
- machine learning
- venous thromboembolism
- acute myocardial infarction
- deep learning
- risk factors
- stem cells
- heart failure
- coronary artery disease
- clinical practice
- wound healing
- mass spectrometry
- replacement therapy
- mesenchymal stem cells
- percutaneous coronary intervention
- cell therapy